Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information

We surveyed 10,303 United States physicians on where they obtain pharmacogenomic testing information. Thirty-nine percent indicated that they obtained this from drug labeling. Factors positively associated with this response included older age, postgraduate instruction, using other information sourc...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanek, Eric J., Sanders, Christopher L., Frueh, Felix W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251399/
https://www.ncbi.nlm.nih.gov/pubmed/25562522
http://dx.doi.org/10.3390/jpm3020111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251399/
https://www.ncbi.nlm.nih.gov/pubmed/25562522
http://dx.doi.org/10.3390/jpm3020111

Ejemplares similares